Last reviewed · How we verify
Pediatric Electrolyte
Pediatric Electrolyte is an oral rehydration solution that replaces water and electrolytes lost through dehydration.
Pediatric Electrolyte is an oral rehydration solution that replaces water and electrolytes lost through dehydration. Used for Pediatric dehydration from acute gastroenteritis, Dehydration from vomiting or diarrhea in children.
At a glance
| Generic name | Pediatric Electrolyte |
|---|---|
| Sponsor | The Hospital for Sick Children |
| Drug class | Oral rehydration solution |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology / Pediatrics |
| Phase | Phase 3 |
Mechanism of action
This is a balanced electrolyte formulation designed to restore fluid and electrolyte homeostasis in pediatric patients experiencing dehydration from diarrhea, vomiting, or other causes. The solution contains sodium, potassium, chloride, and glucose in proportions optimized for pediatric absorption and safety. It works by providing readily absorbable electrolytes and water to correct deficits and maintain normal physiological function.
Approved indications
- Pediatric dehydration from acute gastroenteritis
- Dehydration from vomiting or diarrhea in children
Common side effects
- Hypernatremia (if improperly administered)
- Hypokalemia (if improperly administered)
Key clinical trials
- Determining the Effects of Training on Nursing Students Using Two Different Methods for Maintaining Fluid and Electrolyte Balance in a Child Trapped Under a Collapse (NA)
- Shortened Regimen for Drug-susceptible TB in Children (PHASE3)
- Impact of Clinical Nursing Guideline on Outcomes of Children With Diabetic Ketoacidosis. (NA)
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PHASE3)
- Intravenous Fluid for Pediatric Migraine in the Emergency Department (PHASE1, PHASE2)
- Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors (PHASE1)
- Comparative Efficacy of ARNI Versus ACE Inhibitor Therapy in Egyptian Children With Dilated Cardiomyopathy
- Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |